Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You only lost if you sold. I like where I am sitting right now. I like my seat at the table.
The price doesn't matter right now. If the company executes their business plan you will be up 80% just as quickly.
I have no idea what on Earth you are talking about. I have never called anybody a f****** idiot. I have always said that if the science is sound this will be a good investment but if they can't make it to human trials, we will lose all our money. That has been my message from day one. You are confusing me with somebody else.
Also, if you will read the article that I posted, you will see that Pegan's research at California Riverside is indeed funded by the national institute of health and Sunshin Biopharma. Pegan is still working with UGA as well as Sunshine. Please read the whole article.
Lol, nice research.
Also, this is partially funded by the NIH and Dept of Energy.
First, it was claimed that we would never get to NASDAQ and then it was claimed that we were just paying for research.
Pegan is ready to go on the fast track. Sunshine is ready for prime time in my opinion.
Pl4 and Fast Track is coming.
https://news.ucr.edu/articles/2022/02/24/potential-antiviral-sars-and-sars-coronaviruses
Thanks reallypeople for showing me what I missed last week.
Waiting patiently through the last quiet period here. Things to expect before April-
After 25 days Aegis can issue buy recommendations to their clients. Our stock has a market cap less than the cash on hand. Any way you slice it, this stock is way undervalued.
After the quiet period imposed on Sunshine is over, expect to hear that both PL4 and Adva are moving to Fast Track application and IND studies. I know this is happening because the company already told us this in the filings.
The mice studies for PL4 were a success. The mice studies for Adva were a success. This I know from the filings.
I also expect another appraisal this year reaffirming the billion + value for both drugs.
I expect to win here. Win or lose though, I think the next 6 weeks will tell the story. For that I will be grateful.
LOL, Quebec had some of the strictest Covid rules in North America and most people have been working from home for years. Sunshine Biopharma does not need an office, as all of their work is being done with partners like UGa, McGill, and the unnamed lab in Montreal.
Are you saying that the three executives stole the 8 million dollars? Elaborate on how they are now "millionaires" please.
There is only one reason to go public as a company- to raise money.
To move forward companies take cash in exchange for equity. The question about how SBFM shareholders here got treated will be told in the future.
To believe as you do you must believe that the DD guys at Aegis, the head of oncology research at the Jewish Hospital at McGill, and UGa School of Pharmacy are all in a conspiracy here.
show off. ;)
The market doesn't know anything about Sunshine Biopharma or Steve Slilaty.
Some people got to know about the company, and that resulted in a fund run by doctors buying almost half of the offering.
All of this is about to change.
Adva-27a is a variation of etoposide. The global market for etoposide will be over 1 billion a year this decade. It is used for chemo resistant lung and testicular cancer.
Adva-27a is killing 50% of all cancers in vitro. I can't even imagine the global market for Adva-27a because it may replace etoposide and actually be a solution for countless more types of cancer. HUGE.
Midtermer is a very successful business man who didn't like the deal with Aegis.
I don't like the deal with Aegis either. I will bet, but I don't know for sure, that Sunshine doesn't like the deal with Aegis.
However, we all have to realize that in this economic climate with a fake CIA war supposedly looming (that will never happen in a million years) Sunshine had no choice. We have to move forward.
Sunshine now has 8 million cash + 2 million in cash - 1.9 million in debt. They have their mice trials done and they are ready to petition the FDA for Fast Track.
Our largest investors are now doctors.
We are in a better spot right now that at any time over the last two years.
I knew dilution was coming and I knew the price would drop. I never thought the offering would be so low but the moment the price dropped to a bit below 2.50 buyers took every damn share. I am not sure I have ever seen dilution lapped up so fast. We were averaged 1.3 million shares a day in volume presplit, and using presplit numbers on Tuesday we had 550 million shares bought?
That is not what happens to scams. Aegis dumped and their people cleaned up. I think the GLSI-like move could be next here. We shall see.
I am more confident than ever that Slilaty is going to pull this off. I think he gets both drugs fast tracked.
Slilaty is a freaking genius, but everything he is doing is based off of the successes of others.
Adva-27a is a form of a drug that is currently very successful, but it is less toxic and more effective.
Pl-4 is basically a non-toxic protease inhibitor stops viruses from from using your healthy cells as virus factories. There are many other similar drugs on the market do the same thing for different viruses. Pl-4 is an improvement of what already exists according to Slilaty.
The largest shareholder here is now a fund run by Doctors. They aren't investing in a scam. They see everything I see and much more.
Don't listen to the noise people.
Do you realize that Adva-27a is a modification of etoposide, which is a very successful drug? Adva-27a has been outperforming etoposide during in vitro studies that were done last year. We will next learn about the mice studies that are finished. I know the mice studies are finished but not yet published because the last 10q made reference to IND studies and a Fast Track application for Adva-27a.
There were no trials that failed in France. Sunshine Biopharma now has the intellectual property rights for this drug and finally has the money to move forward.
I suspect that Amplia Pharmatek of Laval has been working along Sunshine since 2012 and duplicated their experiments last year that should clear the way for Fast Track status. I could be totally wrong about that but that would make sense.
This is not some novel drug that is unique. This is a modification that makes a widely used and successful drug more effective.
Are you confusing Laval, France with Laval, the suburb of Montreal? Do you realize that the 3 principals are Lebanese emigrants, and not French?
The "original ip" belongs to Slilaty. The work was done in Laval.
Why would Sunshine be in France? All of their work has been done in Canada.
I would look at the original adva-27a patent. I don't know for a fact, but I think the answer is there.
Almost half of the offering was taken by a 4 billion dollar medical science hedge fund that is run by doctors. I think this fact matters quite a bit.
You could be correct. We shall know soon.
Look at the market cap now....lol, this is such a joke. SBFM is a screaming buy right now.
Yes, this is how companies grow. As a company raises money the percentage of early investor's ownership always decreases.
Talk to me in around March 14th- we will know if Sunshine is for real by then.
Nothing has changed. The price of the stock is meaningless. It is a placeholder for the actual valuation that will only be revealed when the science is revealed. If the stock price is down here mid-March I will be worried, but I don't think it will be. I am holding firm and smiling.
The price does not matter until the science is revealed. It has never mattered absent news.
Aegis told me that over a third of the shares are going to a Medical Science Fund. A VC is taking a quarter of the shares. That means over 60% of the shares are going to groups that want to take a long term position.
This is incredibly encouraging to me.
Camille is hands down the most professional IR person I have encountered. I don't believe for one second he ever alluded to the timing of PRs. He also does not have to issue a PR for a material event- he only needs to issue an 8k or appropriate filing.
The company has 2 million + in cash and 1.9 million in debt is getting paid from the Aegis deal. If there is no debt and cash on the books they technically can pay a dividend.
The dividend is not real. Somebody put up a fake screenshot about a small dividend on Friday morning. I was tricked by this fake screenshot.
This is what makes these posts so effective in driving people away from a stock. I never said that there aren't expenses in a partnership. The words get twisted and the original message is purposely concealed.
All business partnerships have costs. The point is that Georgia is an active participant in the research. McGill is an active partner. If Sunshine is a scam, then Georgia and McGill are in on the scam.
And it was called a scam, and I read the post.
Tenkay is also on record here on this board that Sunshine was just renting lab space at Georgia. Facts just get made up on the fly around here.
Geez..let me slow this down for you.
I wrote "Sunshine is not paying for research. Sunshine is not renting lab space."
They are in active partnerships. There are costs for both sides. The obvious point that you are obfuscating is that UGa and McGill are working with Sunshine to develop solutions. These two fine institutions are not working on a scam.
You called it a scam on this board. I read it and I am not going to sift through your posts to find it.
Nope, because renting a lab and forming a partnership with a non-profit are two very different things. When the head of Cancer Research at one of the greatest Universities in the world is in fact running the show then it does not take a lot of brain power to realize the partnership is not a "scam" (your words).
Who is Gerald Batiste? Who is TRT Pharma?
You have no idea what is going on because you can't learn everything about this company by reading and presenting documents from 2011.
You absolutely called this a scam. I read it on this site.
No, you have not. The Jewish Hospital is sharing costs and working in conjunction with Sunshine.
McGill counts among its alumni and faculty 12 Nobel laureates[23] and 147 Rhodes Scholars,[24] both the most of any university in Canada,[23] as well as 16 billionaires,[note 1] the current prime minister and two former prime ministers of Canada, two Governors General of Canada, 15 justices of the Supreme Court of Canada,[note 2] at least eight foreign leaders, and more than 100 members of national legislatures. McGill alumni also include 8 Academy Award winners,[note 3] 10 Grammy Award winners,[note 4] at least 13 Emmy Award winners,[note 5] four Pulitzer Prize winners,[note 6] and 121 Olympians with over 35 Olympic medals.[27] The inventors of the game of basketball,[28] modern organized ice hockey,[29] and the pioneers of gridiron football,[30] as well as the founders of several major universities and colleges[note 7] are also graduates of the university.
If you say that I should not listen to any poster, why should I listen to you when you tell me to listen to the company? Why do you like to confuse old people?
You should do at least a little research. Sunshine is not paying for research. Sunshine is not renting lab space. They are working in conjunction with the number one pharmacological R and D University in the country and arguably the top teaching hospital in Canada. They are partners in this quest.